This inventor holds 1 USPTO granted patent. Top assignee: Biomerieux, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: David Limal - Innovator in Pseudopeptide Technology
Introduction
David Limal is a notable inventor based in Schiltigheim, France. He has made significant contributions to the field of biochemistry, particularly in the development of pseudopeptides. His work has implications for various applications, including diagnostics and therapeutics.
Latest Patents
David Limal holds a patent for a pseudopeptide, which consists of at least six amino acids. This pseudopeptide includes units selected from specific general formulae, where R, R, and R can represent different amino acid side-chains. The invention also details a synthesis method, a reagent containing the pseudopeptide, and a detection kit for identifying antigens or antibodies. This innovative work has the potential to enhance therapeutic compositions.
Career Highlights
David Limal is currently employed at bioMérieux, Inc., a company renowned for its expertise in diagnostics. His role at the company allows him to further his research and development efforts in the field of pseudopeptides. His contributions are vital to advancing medical diagnostics and treatment options.
Collaborations
David has collaborated with esteemed colleagues such as Jean-Paul Briand and Vincent Semetey. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
David Limal's work in pseudopeptide technology exemplifies the intersection of innovation and practical application in the field of biochemistry. His contributions are paving the way for advancements in diagnostics and therapeutics.